Key Takeaways
- • Michael Buckley, managing director and head of equities at Duquesne Family Office, argues young investors overlook corporate finance fundamentals such as capital structure and debt, skills he says gain importance in the AI era.
- • Buckley says the AI boom depends on debt, as AI companies and infrastructure partners borrow to finance data centers, chips, and computing capacity, making debt analysis relevant to public markets and venture firms.
- • Per the Bank for International Settlements cited in the article, tech hyperscalers issued more than $100 billion in corporate bonds last year.
- • Buckley's credit background at Sankaty Advisors, the credit arm of Bain Capital, led to his recruitment to Duquesne, where he works under Stanley Druckenmiller.
- • Buckley says the firm has backed pharma company Formation Bio and that he has invested in AI, healthcare, and biotech over the past 11 years.
Summary
Michael Buckley, managing director and head of equities at Duquesne Family Office, told Fortune that early-career investors who focus on stock charts, earnings growth, and revenue projections may be overlooking the fundamentals of corporate finance. He argues that concepts such as capital structure and debt, which he described as tedious and complicated, are increasingly important in the AI era.
Buckley's own career was shaped by credit. Immediately after graduating from Harvard, he learned accounting and corporate finance at Sankaty Advisors, the now-renamed credit arm of Bain Capital, where he worked on capital and corporate structures, bonds, and loans. During a two-year stint as an analyst at private equity firm CPMG, a headhunter approached him on behalf of Duquesne, which was seeking a candidate with credit and equities expertise to work under founder Stanley Druckenmiller. He joined as an analyst at age 27.
Buckley argues that the AI boom is closely tied to debt. AI companies and their infrastructure partners are taking on more borrowing to fund data centers, chips, and computing capacity, so investors need to assess both how fast a business can grow and whether it can service its obligations. He says this matters especially for investors in data centers and next-generation labs, and for public markets and venture firms. The article cites the Bank for International Settlements in noting that tech hyperscalers issued more than $100 billion in corporate bonds last year.
At Duquesne, Buckley has focused on AI, healthcare, and biotech over the past 11 years, and he cited a recent Duquesne backing of pharma company Formation Bio. He described himself as a non-dogmatic investor, a philosophy he links to Druckenmiller's broad market perspective. He noted that concerns about credit and interest rates now affect AI infrastructure, private companies, and the venture community, and said he has taken from Druckenmiller the discipline of considering both top-down and bottom-up factors.
Buckley's own career was shaped by credit. Immediately after graduating from Harvard, he learned accounting and corporate finance at Sankaty Advisors, the now-renamed credit arm of Bain Capital, where he worked on capital and corporate structures, bonds, and loans. During a two-year stint as an analyst at private equity firm CPMG, a headhunter approached him on behalf of Duquesne, which was seeking a candidate with credit and equities expertise to work under founder Stanley Druckenmiller. He joined as an analyst at age 27.
Buckley argues that the AI boom is closely tied to debt. AI companies and their infrastructure partners are taking on more borrowing to fund data centers, chips, and computing capacity, so investors need to assess both how fast a business can grow and whether it can service its obligations. He says this matters especially for investors in data centers and next-generation labs, and for public markets and venture firms. The article cites the Bank for International Settlements in noting that tech hyperscalers issued more than $100 billion in corporate bonds last year.
At Duquesne, Buckley has focused on AI, healthcare, and biotech over the past 11 years, and he cited a recent Duquesne backing of pharma company Formation Bio. He described himself as a non-dogmatic investor, a philosophy he links to Druckenmiller's broad market perspective. He noted that concerns about credit and interest rates now affect AI infrastructure, private companies, and the venture community, and said he has taken from Druckenmiller the discipline of considering both top-down and bottom-up factors.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.